期刊文献+

高血压致左室肥厚的发生机制及其治疗进展 被引量:16

下载PDF
导出
摘要 左室肥厚(LVH)是高血压最重要的并发症,在所有高血压患者中20%~30%可有LVH,高血压性LVH是引起猝死、室性心律失常、心肌缺血和心力衰竭等的常见因素。LIFE的研究认为,不管用什么样的治疗方式或是否降压,心血管疾病的发病率都会随LVH的消退而降低。Conrady等研究认为,通过严格控制血压水平可以逆转高血压LVH。逆转左心室肥厚的治疗能改善高血压病人的预后,并减少心血管疾病的发病率和死亡率。本文就近年来逆转高血压LVH药物治疗的机制及其进展作一综述。
作者 孙莉 李树青
出处 《中国心血管病研究》 CAS 2007年第4期315-317,共3页 Chinese Journal of Cardiovascular Research
  • 相关文献

参考文献14

  • 1[1]Braz Nogueira J.Regression of left ventricular hypertrophy in hypertension-does it reduce cardiovascular risk?Rev Port Cardiol,2005,24:1007-1013.
  • 2[2]Conrady AO,Rudomanov OG,Zaharov DV,et al.Prospective study of the changes in left ventricular mass and geometry patterns in hypertensive patients During 5 years of follow-up.Circ J,2005,69:1374-1379.
  • 3[3]Okin PM,Devereux RB,Jern S,et al.Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.JAMA,2004,292:2396-2398.
  • 4[4]O'Brien E.Aliskiren:a renin inhibitor offering a new approach for the treatment of hypertension.Expert Opin Investig Drags.2006,15:1269-77.
  • 5[5]Ishani A,Weinhandl E,Zhao Z,et al.Angiotensin-converting enzyme inhibitor as a risk factor for thedevelopment of anemia,and the impact of incident anemia onmortality in patients with left ventricular dysfunction.J AmColl Cardiol,2005,45:391.
  • 6[6]Sugaya,Hw Lju,TX Cui,et al.Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on Vascular injury.Hypertension,2003,42:542-547.
  • 7[7]Jorger R.Kizer,Bjom Dahlof,Sverre E.Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol:the losartan intervention.for endpeint reduction in hypertension study.Hypertension,2005,45:46-52.
  • 8[8]Pitt B,Reichek N,Willenbrock R,et al.Effects of eplerenone,enalapril,and epterenone/enalapril in patients with essential hypertension and left ventricular hypertrophy:the 4E-left ventric ular hypertrophy study.Circulation,2003,108:1831-1838.
  • 9[9]Emoto N,Raharjo SB,Isaka D.Dual ECE/NEP inhibition on cardiac and neurohumoral function during the transition from hypertrophy to heart failure in rats.Hypertension,2005,45:1145-1152.
  • 10[10]Oudit GY,Grackower MA,Backx PH,et al.The role of ACE2 in cardiovascular physiolopy.Trends Cardilovasc Med,2003,13:93-101.

二级参考文献10

  • 1黄熙,臧益民.丹参酮ⅡA磺酸钠心血管药理[J].国外医学(中医中药分册),1995,17(1):9-12. 被引量:66
  • 2Motz W,Vogt M,Scheler S,et al.Pharmacotherapeutic effects of antihypertensive agents on myocardium and coronary arteries in hypertension.Eur Heart J,1992,13:100-106.
  • 3Jacobi J,Schlaich MP,Delles C,et al.Angiotensin Ⅱ stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure.Am J Hypertens,1999,12:418-422.
  • 4Brilla CG,Janicki JS,Wever KT.Cardioreparatice effect of lidinopril in rat with genetic hypertrophy and left ventricular hypertrophy.Circulatio,1991,83;1771-1775.
  • 5Brilla CG,Janicki JS,Wever KT,et al.Impaired diasolic function and coronary reserve in genetic hypertension.Circulation,1997,96:3027-3078.
  • 6Claude D,Jean SS,Anne G,et al.Cardiac aldosterone production and ventricular remodeling.Kidney International,2000,57:1346-1351.
  • 7Yoshiyu T,Takashi Y,Masashi D,et al.Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy.Endocrinology,2000,141:1901-1904.
  • 8Valerie R,Christophe H,Jean S S,et al.Angiotensin AT1 recepter subtype as a cardiac target of aldosterone:role on aldosterone-salt-induced fibrosis.Hypertension,1999,33:981-986.
  • 9杜宏,李俭春,李辉.自发性高血压大鼠心肌胶原增生与心肌局部血管紧张素Ⅱ及醛固酮[J].高血压杂志,1997,5(1):17-19. 被引量:9
  • 10吴平生,梁欣伟,郭志刚,张远慧,刘伊丽,聂道海,刘品明,郭庆秋,张榕华,赖文岩.丹参酮Ⅱ-A抑制血管合成醛固酮及醛固酮合酶基因CYP11B2信使核糖核酸表达[J].中国循环杂志,1998,13(3):175-177. 被引量:14

共引文献57

同被引文献173

引证文献16

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部